Your browser doesn't support javascript.
loading
The added value of PSMA PET/MR radiomics for prostate cancer staging.
Solari, Esteban Lucas; Gafita, Andrei; Schachoff, Sylvia; Bogdanovic, Borjana; Villagrán Asiares, Alberto; Amiel, Thomas; Hui, Wang; Rauscher, Isabel; Visvikis, Dimitris; Maurer, Tobias; Schwamborn, Kristina; Mustafa, Mona; Weber, Wolfgang; Navab, Nassir; Eiber, Matthias; Hatt, Mathieu; Nekolla, Stephan G.
Affiliation
  • Solari EL; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. elucas.solari@tum.de.
  • Gafita A; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Schachoff S; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Bogdanovic B; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Villagrán Asiares A; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Amiel T; School of Medicine, Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Hui W; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Rauscher I; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Visvikis D; INSERM, UMR 1101, LaTIM, Univ Brest, Brest, France.
  • Maurer T; Department of Urology and Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Schwamborn K; School of Medicine, Institute of Pathology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Mustafa M; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Weber W; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Navab N; School of Computer Science, Computer Aided Medical Procedures and Augmented Reality, Technical University Munich, Munich, Germany.
  • Eiber M; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Hatt M; INSERM, UMR 1101, LaTIM, Univ Brest, Brest, France.
  • Nekolla SG; School of Medicine, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Eur J Nucl Med Mol Imaging ; 49(2): 527-538, 2022 01.
Article de En | MEDLINE | ID: mdl-34255130
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Imagerie par résonance magnétique multiparamétrique Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Eur J Nucl Med Mol Imaging Sujet du journal: MEDICINA NUCLEAR Année: 2022 Type de document: Article Pays d'affiliation: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Imagerie par résonance magnétique multiparamétrique Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Eur J Nucl Med Mol Imaging Sujet du journal: MEDICINA NUCLEAR Année: 2022 Type de document: Article Pays d'affiliation: Allemagne